drug

NRTX-1001

Phase 3updated 3mo ago

by Neurona Therapeutics Inc

Phase 3

community read0 votes

indications

Epilepsy

all catalysts(0)

nothing on the calendar yet

Trials studying NRTX-1001

phase3Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))recruitingn=88
phase2A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)recruitingn=10

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

NRTX-1001

Phase 3updated 3mo ago

by Neurona Therapeutics Inc

Phase 3

community read0 votes

indications

Epilepsy

all catalysts(0)

nothing on the calendar yet

Trials studying NRTX-1001

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

NRTX-1001

indications

all catalysts(0)

Trials studying NRTX-1001

News(0)

Report a data issue

comments(0)

NRTX-1001

indications

all catalysts(0)

Trials studying NRTX-1001

News(0)

Report a data issue

comments(0)